ATP11A inhibitors belong to a specific class of chemical compounds designed to target and inhibit the activity of the ATP11A protein. ATP11A, short for ATPase phospholipid transporting 11A, is a transmembrane protein primarily found in the membranes of various cellular organelles, including the endoplasmic reticulum and Golgi apparatus. Its fundamental function is to facilitate the translocation of phospholipids between these membrane compartments, playing a crucial role in maintaining membrane asymmetry, cellular lipid homeostasis, and vesicle trafficking. Inhibition of ATP11A activity can disrupt these processes, leading to alterations in membrane composition and structure.
ATP11A inhibitors are designed with the aim of modulating ATP11A's function. These inhibitors typically work by binding to the ATP11A protein, either directly or indirectly, and preventing its normal phospholipid translocation activity. By doing so, they disrupt the precise regulation of lipid distribution within the cell, potentially affecting vital cellular processes such as membrane trafficking, signal transduction, and membrane integrity. The development and study of ATP11A inhibitors are of interest in the field of cell biology and molecular pharmacology, as they can provide valuable insights into the role of phospholipid transporters in cellular physiology and the potential consequences of their dysregulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+ ATPases, potentially altering ion gradients that could influence ATP11A activity. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
Targets Na+/K+ ATPases, might affect ATP11A indirectly by disturbing ion homeostasis. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Specific inhibitor of V-ATPases, could disrupt proton gradients, indirectly affecting ATP11A. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SERCA pump, leading to altered Ca2+ balance, may affect ATP11A indirectly. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
SERCA inhibitor, alters Ca2+ storage and could indirectly influence ATP11A function. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits F-type ATPases, could indirectly affect ATP11A by altering ATP availability. | ||||||
Sodium metavanadate | 13718-26-8 | sc-251034 sc-251034A | 5 g 25 g | $32.00 $84.00 | 3 | |
Inhibits several P-type ATPases, may affect ATP11A by competing for ATP binding. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Inhibits cytochrome c oxidase, could reduce ATP synthesis, indirectly affecting ATP11A. | ||||||
DCC | 538-75-0 | sc-239713 sc-239713A | 25 g 100 g | $72.00 $208.00 | 3 | |
Binds to and inhibits many ATPases, possibly affecting ATP11A indirectly. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker, could impact Ca2+ balance and indirectly affect ATP11A. | ||||||